Tags

Type your tag names separated by a space and hit enter

A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pancreas 2014; 43(2):190-7P

Abstract

Clinical trials evaluating the protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs) for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) have yielded inconclusive results. Our objective was to conduct a meta-analysis of the data to date to evaluate the efficacy and safety of rectal NSAIDs for PEP prophylaxis. We did a systematic search of PubMed/MEDLINE, Embase, and Web of Science databases and the Cochrane Central Register of Controlled Trials. The meta-analysis was performed using a fixed-effect method because of the absence of significant heterogeneity in the included trials. Seven randomized, controlled trials involving 2133 patients were included. The meta-analysis showed that rectal NSAIDs decreased the overall incidence of PEP (risk ratio, 0.44; 95% confidence interval, 0.34-0.57; P < 0.01). The number needed to treat was 11. The NSAID prophylaxis also decreased the incidence of moderate to severe PEP (risk ratio, 0.37; 95% confidence interval, 0.27-0.63; P < 0.01). The number needed to treat was 34. No differences of the adverse events attributable to NSAIDs were observed. In conclusion, prophylactic use of rectal NSAIDs reduces the incidence and severity of PEP. There is neither a difference in efficacy between rectal indomethacin and diclofenac nor a difference in efficacy between the timing of administration of rectal NSAIDs, that is, immediate pre-ERCP and post-ERCP.

Authors+Show Affiliations

From the *Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; and †Department of Internal Medicine, Pushpanjali Crosslay Hospital, New Delhi, India.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Meta-Analysis
Review

Language

eng

PubMed ID

24518496

Citation

Sethi, Saurabh, et al. "A Meta-analysis On the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis." Pancreas, vol. 43, no. 2, 2014, pp. 190-7.
Sethi S, Sethi N, Wadhwa V, et al. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas. 2014;43(2):190-7.
Sethi, S., Sethi, N., Wadhwa, V., Garud, S., & Brown, A. (2014). A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas, 43(2), pp. 190-7. doi:10.1097/MPA.0000000000000090.
Sethi S, et al. A Meta-analysis On the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas. 2014;43(2):190-7. PubMed PMID: 24518496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. AU - Sethi,Saurabh, AU - Sethi,Nidhi, AU - Wadhwa,Vaibhav, AU - Garud,Sagar, AU - Brown,Alphonso, PY - 2014/2/13/entrez PY - 2014/2/13/pubmed PY - 2014/10/21/medline SP - 190 EP - 7 JF - Pancreas JO - Pancreas VL - 43 IS - 2 N2 - Clinical trials evaluating the protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs) for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) have yielded inconclusive results. Our objective was to conduct a meta-analysis of the data to date to evaluate the efficacy and safety of rectal NSAIDs for PEP prophylaxis. We did a systematic search of PubMed/MEDLINE, Embase, and Web of Science databases and the Cochrane Central Register of Controlled Trials. The meta-analysis was performed using a fixed-effect method because of the absence of significant heterogeneity in the included trials. Seven randomized, controlled trials involving 2133 patients were included. The meta-analysis showed that rectal NSAIDs decreased the overall incidence of PEP (risk ratio, 0.44; 95% confidence interval, 0.34-0.57; P < 0.01). The number needed to treat was 11. The NSAID prophylaxis also decreased the incidence of moderate to severe PEP (risk ratio, 0.37; 95% confidence interval, 0.27-0.63; P < 0.01). The number needed to treat was 34. No differences of the adverse events attributable to NSAIDs were observed. In conclusion, prophylactic use of rectal NSAIDs reduces the incidence and severity of PEP. There is neither a difference in efficacy between rectal indomethacin and diclofenac nor a difference in efficacy between the timing of administration of rectal NSAIDs, that is, immediate pre-ERCP and post-ERCP. SN - 1536-4828 UR - https://www.unboundmedicine.com/medline/citation/24518496/A_meta_analysis_on_the_role_of_rectal_diclofenac_and_indomethacin_in_the_prevention_of_post_endoscopic_retrograde_cholangiopancreatography_pancreatitis_ L2 - http://Insights.ovid.com/pubmed?pmid=24518496 DB - PRIME DP - Unbound Medicine ER -